FDA Inspection 1304030 — Jessica Jiyeong Lin, MD

Jessica Jiyeong Lin, MD — FEI 3041147380

The FDA completed an inspection of Jessica Jiyeong Lin, MD on February 13, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 13, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)